Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls

Similar documents
Family Medicine for English language students of Medical University of Lodz ECG. Jakub Dorożyński

5- The normal electrocardiogram (ECG)

This presentation will deal with the basics of ECG description as well as the physiological basics of

Electrocardiogram ECG. Hilal Al Saffar FRCP FACC College of medicine,baghdad University

ECG Interpretation Made Easy

BTL CardioPoint Relief & Waterfall. Relief & Waterfall. Abnormalities at first sight

HST-582J/6.555J/16.456J-Biomedical Signal and Image Processing-Spring Laboratory Project 1 The Electrocardiogram

ECG INTERPRETATION MANUAL

Interpreting Electrocardiograms (ECG) Physiology Name: Per:

» A new drug s trial

ECG CONVENTIONS AND INTERVALS

DIFFERENCE-BASED PARAMETER SET FOR LOCAL HEARTBEAT CLASSIFICATION: RANKING OF THE PARAMETERS

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Testing the Accuracy of ECG Captured by Cronovo through Comparison of ECG Recording to a Standard 12-Lead ECG Recording Device

BASIC CONCEPT OF ECG

Medicine. Dynamic Changes of QRS Morphology of Premature Ventricular Contractions During Ablation in the Right Ventricular Outflow Tract

Electrocardiography Biomedical Engineering Kaj-Åge Henneberg

ATRIAL FIBRILLATION FROM AN ENGINEERING PERSPECTIVE

Comparison of Different ECG Signals on MATLAB

Introduction to ECG Gary Martin, M.D.

Module 1: Introduction to ECG & Normal ECG

DR QAZI IMTIAZ RASOOL OBJECTIVES

UNDERSTANDING YOUR ECG: A REVIEW

AUTOMATIC ANALYSIS AND VISUALIZATION OF MULTILEAD LONG-TERM ECG RECORDINGS

P-wave Indices to Detect Susceptibility to Atrial Fibrillation

Full file at

ECG. Prepared by: Dr.Fatima Daoud Reference: Guyton and Hall Textbook of Medical Physiology,12 th edition Chapters: 11,12,13

ECG interpretation basics

Understanding basics of EKG

ATHENA - A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular

available at journal homepage:

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Journal of the American College of Cardiology Vol. 38, No. 5, by the American College of Cardiology ISSN /01/$20.

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD

NIH Public Access Author Manuscript Comput Cardiol (2010). Author manuscript; available in PMC 2011 July 11.

Electrocardiography Abnormalities (Arrhythmias) 7. Faisal I. Mohammed, MD, PhD

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

HST.582J / 6.555J / J Biomedical Signal and Image Processing Spring 2007

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Prediction of Atrial Fibrillation using Wavelet P-wave Detector

CASE 10. What would the ST segment of this ECG look like? On which leads would you see this ST segment change? What does the T wave represent?

Lecture outline. Electrical properties of the heart. Automaticity. Excitability. Refractoriness. The ABCs of ECGs Back to Basics Part I

EKG. Danil Hammoudi.MD

ECG ABNORMALITIES D R. T AM A R A AL Q U D AH

By the end of this lecture, you will be able to: Understand the 12 lead ECG in relation to the coronary circulation and myocardium Perform an ECG

Exploration of Supraventricular Conduction with respect to Atrial Fibrillation. Methodological Aspects on Selected Techniques

ECGs on the acute admission ward. - Cardiology Update -

EHRA/EUROPACE 2011 Madrid, Spain June

Birmingham Regional Emergency Medical Services System

Atrial Fibrillation Ablation in Patients with Heart Failure

Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation

The Efficient and Smart Methods for Diagnosis of SVT 대구파티마병원순환기내과정병천

The Experimental Study of Normal Atrial T Wave (Ta) in Electrocardiograms

Understanding the 12-lead ECG, part II

12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP

How to Ablate Atrial Tachycardia Mechanisms and Approach. DrJo Jo Hai

ECG Signal Characterization and Correlation To Heart Abnormalities

Ankara, Turkey 2 Department of Cardiology, Division of Arrhythmia and Electrophysiology, Yuksek Ihtisas

Electrocardiography I Laboratory

CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY

Simulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance

Signal Processing of Stress Test ECG Using MATLAB

Interventional solutions for atrial fibrillation in patients with heart failure

Wide QRS Tachycardia in a Dual Chamber Pacemaker Patient: What is the Mechanism?

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

12 LEAD EKG BASICS. By: Steven Jones, NREMT P CLEMC

Sustained tachycardia with wide QRS

Chapter 3. Electrocardiographic Characteristics in Low Atrial Septum Pacing.

Relax and Learn At the Farm 2012

Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013

ABCs of ECGs. Shelby L. Durler

CLINICAL CARDIOLOGY: ORIGINAL ARTICLE

Collin County Community College

EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology

Diploma in Electrocardiography

ECG Interpretation Cat Williams, DVM DACVIM (Cardiology)

Automatic Detection of Abnormalities in ECG Signals : A MATLAB Study

12 Lead ECG Interpretation: The Basics and Beyond

IJRIM Volume 1, Issue 2 (June, 2011) (ISSN ) ECG FEATURE EXTRACTION FOR CLASSIFICATION OF ARRHYTHMIA. Abstract

Cover Page. The handle holds various files of this Leiden University dissertation

a lecture series by SWESEMJR

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.

Chapter 2 Practical Approach

New Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram

ARRHYTHMIAS IN THE ICU

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

Supraventricular Arrhythmias. Reading Assignment. Chapter 5 (p17-30)

ICD in a young patient with syncope

J-wave syndromes: update on ventricular fibrillation mechanisms

Biatrial Stimulation and the Prevention of Atrial Fibrillation

ECG (MCQs) In the fundamental rules of the ECG all the following are right EXCEP:

Miscellaneous Stuff Keep reading the Outline

CARDIOVASCULAR PHYSIOLOGY ECG. Dr. Ana-Maria Zagrean

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population

Cardiac memory is a T-wave change that follows ventricular

ISSN: ISO 9001:2008 Certified International Journal of Engineering and Innovative Technology (IJEIT) Volume 2, Issue 10, April 2013

Errors in manual measurement of QT intervals

A hybrid wavelet and time plane based method for QT interval measurement in ECG signals

Transcription:

672 Acta Cardiol 2015; 70(6): 672-677 doi: 10.2143/AC.70.6.3120179 [ Original article ] Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls Daniele GIACOPELLI 1, MSc; John P. BOURKE 2, MD; Philip LANGLEY 3, PhD 1 Biotronik Italia, Milano, Italy; 2 Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK; 3 School of Engineering, University of Hull, Hull, UK. Objective The aim of this study is to characterize the observable segment of the atrial repolarization (Ta wave) of the standard ECG during sinus rhythm in paroxysmal atrial fibrillation (PAF) patients and controls. Methods Ta and P waves were measured from signal-averaged recordings of a standard 12-lead ECG in 40 patients, 20 with PAF, but in SR at the time of recording, and 20 healthy controls. Wave amplitudes and morphologies were measured. Results There were no significant differences in Ta amplitude between the PAF patients and controls. A subgroup analysis of patients on and off anti-arrhythmic drugs also showed no significant differences in Ta amplitudes. For both groups Ta wave had opposite polarity to the monophasic P wave. Biphasic P waves had Ta polarity opposite to the initial phase of the P wave. Ta wave amplitudes were largest in leads II (mean ± SD, 25 ± 16 µv), V2 ( 22 ± 10 µv), V3 ( 21 ± 10 µv) and V4 ( 20 ± 8 µv). A significant correlation was found between Ta and P wave amplitudes, leads recording larger P waves also had larger Ta waves (PAF group: r = 0.15 (P = 0.02) PAF vs r = 0.33 (P = 0.002) HC). Conclusion No differences in the amplitude of the observable section of the atrial repolarization phase of the ECG could be observed between patients with PAF and controls. Ta wave correlates with the corresponding P wave in both amplitude and polarity. Keywords Atrial repolarization atrial depolarization Ta wave P wave morphology atrial fibrillation. Introduction Atrial repolarization has received little attention to date and little has been published on the atrial repolarization phase on the electrocardiogram (ECG). This is probably due to the fact that much of this phase of the ECG is obscured by the large ventricular activity. The only observable part of atrial repolarization is during the short PQ segment of the ECG. The atrial repolarization phase is known as the atrial T wave or Ta wave. Its amplitude is small and signal averaging is necessary to derive accurate measurements 1,2. Given the importance of abnormal ventricular repolarization in the development of ventricular arrhythmias, Address for correspondence: Daniele Giacopelli, MSc, Via Maffei 11, Albinea, 42020, Italy. E-mail address: giacopellid@gmail.com Received 25 May 2015; accepted for publication 2 June 2015. the study of the atrial repolarization and its association with atrial arrhythmia is timely. Analysis of the Ta wave during periods of sinus rhythm might contain important information about propensity to atrial arrhythmias, similar to that of the T wave in the case of some ventricular arrhythmias 3. Intracardiac electrophysiology studies have already shown abnormalities of atrial repolarization in patients with paroxysmal atrial fibrillation 4. These include, for example, a progressive shortening of the atrial refractory period 5. If these changes persist during periods of sinus rhythm, abnormalities of atrial repolarization might be apparent on the Ta wave. Of course it is not possible to derive any Ta wave during atrial fibrillation itself since the continuous rapid activation of the atria means that there is no PQ segment on the ECG. One small previous study was unable to show any significant difference in Ta amplitude or polarity between patients with a history of AF and those without 6. Others have shown that in patients with complete AV-block, where the full atrial repolarization phase may be observable (dependent upon AV synchronization) the Ta peak is usually located over 200 ms

The ECG-Ta wave 673 after the onset of the P wave. This means that in patients with normal AV-conduction it is located typically in the subsequent QRS complex 5. Therefore in normal sinus rhythm the end of the Ta wave is completely obscured by the large ventricular activity so atrial repolarization duration cannot be measured. However, the morphology of the Ta wave might yield diagnostic information but so far there have been few pioneering descriptions of the morphology of the Ta wave and its relationship to the P wave 7,8. Therefore the aim of this study was to characterise atrial repolarization in terms of its amplitude and polarity from the short observable segment of the surface ECG. In particular relating the Ta wave to the corresponding atrial depolarisation phase, the P wave, in patients with paroxysmal atrial fibrillation (PAF) and controls without any arrhythmia or cardiac diagnoses. Methods Patient population The patient group comprised 20 subjects, all males, diagnosed with PAF, but all in SR at the time of data collection (PAF group). Patients were recruited from those referred to the Arrhythmia Services at the Freeman Hospital and listed for catheter ablation of AF for standard clinical indications. Median (range) duration of diagnosis of AF was 4.5 (1-15) years. Cardioactive medications of the PAF group were antiarrhythmic drugs, ACE inhibitors, antiplatelet drugs, anticoagulation therapy, beta blockers in 14 (70%), 5 (25%), 7 (35%), 5 (25%) and 7 (35%) patients, respectively. The healthy control group (HC group) comprised 20 males without arrhythmia or known heart disease. Both groups were similar in age (mean (range)) (HC vs PAF: 49 (42-62) vs 49 (44-58) years; P > 0.05) and heart rate in SR (mean ± SD) (64 ± 11 vs 63 ± 11 beats per minute; P > 0.05). No atrioventricular block of any degree was present in the subjects of both groups. Data acquisition and analysis Twelve-lead ECG was recorded in all subjects for 600 s. ECG was sampled at 500 Hz with an amplitude resolution of less than 5 µv. Recordings were transferred to a central database for subsequent off-line processing. Pre-processing of signals consists of 3 infinite impulse response elliptical filters: a high pass filter with cut-off frequency of 0.05 Hz, a low pass filter with cut-off frequency of 100 Hz and a notch filter to suppress main line interference. A QRS detector was used to identify individual cardiac beats and detected R wave peaks were manually verified by visual inspection. Ectopic beats were removed from the analysis. Knowing the locations of the R peak in each beat, a window containing the atrial beat was defined. The window was chosen such that it included a segment before onset of the P wave, the P wave and the observable Ta wave up to the onset of the Q wave. These features were captured by a window of 270 ms duration located to start 320 ms before the R peak in each beat. For each lead the average atrial beat was computed from the collection of all beat windows. To minimise the effect of P and Ta wave morphology changes due to RR changes, only beats with RR intervals within 1% of the most common (mode) were used to generate the average atrial beat in each lead. As a further measure to ensure correct alignment of atrial beats, the beats were aligned by maximum correlation before calculating the average atrial beat. On the resulting average beat an isoelectric window of 80 ms duration positioned before the onset of the P wave was selected to define the baseline amplitude. The mean value in this window was subtracted from the average beat to remove the baseline offset. The standard deviation calculated in the same window was considered as an estimation of the noise on the signal. Each P wave was classified on the basis of its morphology as up-right (one positive phase), biphasic up-down (two phases, the first positive and the second negative), down-right (one negative phase), biphasic down-up (two phases, the first negative and the second positive). The observable Ta wave is generally seen as a relatively flat waveform, offset from the baseline, directly after the end of the P wave. Hence, the Ta wave amplitude was estimated as the average amplitude in a window after the end of the P wave. This window was defined manually in the flattest segment before Q wave onset. Examples of the four P wave morphologies and Ta waves are shown in figure 1. Ta waves were measured in all the 12 leads for all the subjects of the two groups. The same was performed for the P waves; their amplitude was measured as the peak for monophasic morphologies and as the difference between the positive and the negative peaks for biphasic morphologies. Statistical analysis Statistical analysis of the data was performed in Matlab 7.6.0 and in SigmaPlot 8.0 (Systat Software Inc). The unpaired Student s T-test with two tails was used to test for significant differences in the Ta wave amplitude between groups (PAF-HC; AADs on -AADs off), while to test differences between (i) the 12 leads and

674 D. Giacopelli et al. Results Ta wave amplitude Table 1 shows the signed and absolute Ta wave amplitudes for all the leads in the PAF and HC groups. No significant differences in Ta amplitude were identified between the groups. A subgroup analysis of patients on and off anti-arrhythmic drugs also showed no significant differences in Ta amplitudes (table 2). However, this result needs to be treated cautiously due to the small number of subjects in this subgroup analysis. Combining data from both the PAF and HC groups, Ta amplitude differed significantly between leads. Leads with the largest Ta-wave amplitude were II (mean ± SD, 25 ± 16 µv), V2 ( 22 ± 10 µv), V3 ( 21 ± 10 µv), V4 ( 20 ± 8 µv). Noise amplitude on the signal was of the order of a 1/10 th of the Ta wave amplitude. Correlation between Ta wave amplitude and P wave amplitude Fig. 1 Four examples of atrial depolarization (P wave) and repolarization (Ta wave) for different P-wave morphologies. (a) Up-right P wave and negative Ta wave, (b) biphasic up-down P wave and a negative Ta wave, (c) down-right P wave and positive Ta wave, (d) biphasic down-up P wave and positive Ta wave, here the onset of the QRS complex is visible at 250 ms. (ii) morphology categories, the ANOVA test was used. Correlation between Ta wave amplitude and P wave amplitude was analysed with the Pearson s coefficient (r). The differences were considered significant with P < 0.05. We assessed the correlation between the magnitude of atrial depolarization and repolarization phases using absolute amplitude values of P and Ta waves in all leads (figure 2). As expected there was a significant positive correlation in both groups indicating that larger Ta waves are associated with larger P waves. However, the correlation was weaker for the PAF group than for the HC subjects [PAF: r = 0.15 (P = 0.02); HC: r = 0.33 (P = 0.002)]. Relationship between Ta wave polarity and P wave morphology The majority of P-wave morphologies in leads I, II and the left precordial leads had up-right P waves (Table 3). Table 1 Actual and absolute Ta wave amplitude for PAF and HC groups among the 12 leads Lead Mean Ta amplitude [stdev] (µv) P value Mean absolute Ta amplitude [stdev] (µv) P value PAF group HC group PAF group HC group I 14 [8] 13 [6] 0.50 14 [8] 13 [6] 0.38 II 22 [8] 27 [10] 0.13 22 [8] 27 [10] 0.12 III 8 [10] 11 [12] 0.42 10 [8] 14 [7] 0.05 avr 19 [7] 20 [8] 0.81 19 [7] 20 [8] 0.61 avl 5 [7] 1 [6] 0.13 7 [5] 5 [3] 0.16 avf 15 [9] 19 [9] 0.11 15 [8] 19 [9] 0.17 V 1 10 [11] 12 [14] 0.56 13 [8] 14 [13] 0.48 V 2 20 [16] 22 [11] 0.61 24 [20] 22 [10] 0.56 V 3 22 [17] 18 [12] 0.43 26 [9] 19 [10] 0.05 V 4 20 [11] 18 [11] 0.51 22 [7] 18 [10] 0.19 V 5 15 [9] 17 [8] 0.54 17 [5] 17 [8] 0.65 V 6 12 [7] 15 [8] 0.29 13 [5] 15 [7] 0.34

The ECG-Ta wave 675 Table 2 Ta wave amplitude for PAF patients on (AADs on) and off (AADs off ) antiarrhythmic drugs Lead Mean actual Ta amplitude [stdev] (µv) P value AADs on AADs off I 14 [9] 14 [8] 0.88 II 20 [7] 28 [9] 0.05 III 6 [10] 12 [11] 0.23 avr 18 [7] 22 [7] 0.25 avl 6 [7] 2 [6] 0.29 avf 12 [8] 20 [9] 0.07 V1 10 [12] 9 [9] 0.86 V2 19 [14] 21 [23] 0.82 V3 22 [13] 22 [26] 0.99 V4 18 [11] 26 [7] 0.11 V5 14 [9] 20 [6] 0.14 V6 11 [7] 16 [5] 0.15 Lead avr always had a down-right P wave morphology. In other leads morphologies were more variable. Ta wave polarity and amplitude were significantly different among the four P wave morphology categories (P = 0.003) for PAF and HC groups (figure 3). up-right P waves had negative Ta waves in both groups (PAF: 18 ± 13 µv; HC: 19 ± 11 µv). biphasic up-down P waves also had negative Ta waves (PAF: 12 ± 7 µv; HC: 14 ± 11 µv). Down-right P waves had positive Ta waves for both groups (PAF: 15 ± 9 µv; HC: 17 ± 9 µv). Biphasic down-up P waves also had positive Ta waves (PAF: 7 ± 6 µv; HC: 4 ± 3 µv). Discussion Signal-averaged P wave is the most validated method of recording P-waves for detailed analysis 9-12. In the present study we extend this methodology to allow Fig. 2 Relationship between absolute P wave amplitude and the absolute Ta wave amplitude for PAF and HC groups. Pearson s correlation was weaker for the PAF group (r = 0.15 (P = 0.02)) than for the HC group (r = 0.33 (P = 0.002)). Table 3 The distribution of P wave morphologies in the 12 leads for PAF and HC groups Lead Up right Biphasic up down Down right Biphasic down up PAF HC PAF HC PAF HC PAF HC I 20 20 II 18 20 2 III 4 11 11 5 5 3 1 avr 20 20 avl 17 10 1 2 3 7 avf 11 17 8 3 1 V 1 4 17 15 3 1 V 2 16 15 2 5 1 1 V 3 18 19 1 1 1 V 4 18 20 1 1 V 5 19 20 1 V 6 19 20 1 The table specifies the number of subjects with each P wave morphology category in all leads. P wave morphologies are the following: up-right (one positive phase), biphasic up-down (two phases, the first positive and the second negative), down-right (one negative phase), biphasic down-up (two phases, the first negative and the second positive).

676 D. Giacopelli et al. Fig. 3 Relation between P wave morphology categories and Ta wave amplitude. analysis of the Ta segment and provide insights into atrial repolarization from the surface ECG. Previous studies have reported differences in the duration and timing of the Ta wave peak between healthy subjects and patients with AF history 5,10,13,14. In our study we focused on the amplitude and polarity of the Ta wave, observable in SR, and on its relationship to P wave morphology. Leads II, V2, V3 and V4 had the largest Ta wave representation. Lead II would be expected to be the lead most parallel to the atrial repolarization propagation vector, while the first left precordial leads are the nearest ones to the atria. Similar to the findings of others previously 6, we found that the observable section of the atrial repolarization phase of the ECG in patients with PAF was similar to that in healthy controls. Moreover, we were not able to see any differences in amplitude between PAF patients in therapy with antiarrhythmic drugs from PAF patients without. Since in sinus rhythm we are only able to examine the observable section of atrial repolarization in the PQ interval of the ECG differences in atrial repolarization outside of this interval can only be investigated by invasive studies. As expected, a positive correlation was found between the absolute value of Ta wave and P wave amplitudes. This was stronger in the HC group. The weaker correlation between magnitude of depolarization and repolarization phases in the PAF group might indicate that atrial repolarization is less organised with increased dispersion of atria repolarization in PAF patients. A strong link was observed between P and Ta wave morphologies. Four distinct P-wave morphologies were identified, each having a consistent pattern of Ta wave polarities: negative Ta waves for up-right and biphasic up-down P waves; positive Ta waves for down-right and biphasic down-up P waves. The Ta wave invariably has the opposite polarity to the P wave and, in the case of biphasic P waves, the opposite polarity to the first phase of the P wave. This indicates that repolarization propagation proceeds in a similar but opposite direction to depolarization in the atria and this does not change in PAF during SR. A limitation of our study was that the majority of the PAF patients received anti-arrhythmic medications and the effect of these on the Ta wave are unknown. Further analysis of atrial repolarization on a larger group of patients, stratified by anti-arrhythmic drugs, atrial dimensions and severity of arrhythmic burden is warranted. Conclusion The observable segment of the atrial repolarization phase of the ECG exhibits a consistent morphological relationship with the atrial depolarization phase and this relationship is unaltered in PAF. Conflict of interest: none. References 1. Ihara Z, Van Oosterom A, Hoekema R. Atrial repolarization as observable during the PQ interval. J Electrocardiol 2006; 39: 290-7. 2. Holmqvist F, Carlson J, Platonov PG. Detailed ECG analysis of atrial repolarization in humans. Ann Noninvasive Electrocardiol 2009; 14: 13-8. 3. Malik M, Batchvarov VN. Measurement interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749-66. 4. Li Z, Hertervig E, Yuan S, Yang Y, Lin Z, Olsson SB. Dispersion of atrial repolarisation in patients with paroxysmal atrial fibrillation. Europace 2001; 3: 285-91. 5. Holmqvist F, Carlson J, Waktare JE, Platonov PG. Noninvasive evidence of shortened atrial refractoriness during sinus rhythm in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2009; 32: 302-7.

The ECG-Ta wave 677 6. Langley P, Murray A. Analysis of the atrial repolarisation phase of the ECG in health and in atrial fibrillation. Comput Cardiol 2007; 34: 785-8. 7. Sprague HB, White PD. Clinical observations on the T wave of the auricle appearing in the human electrocardiogram. J Clin Invest 1925; 1: 389-402. 8. Brody DA, Arzbaecher RC, Woolsey MD, Sato T. The normal atrial electrocardiogram: Morphologic and quantitative variability in bipolar extremity leads. Am Heart J 1967; 74: 4-12. 9. Platonov PG, Carlson J, Ingemansson MP, Roijer A, Hansson A, Chireikin LV, Olsson SB. Detection of inter-atrial conduction defects with unfiltered signal-averaged P-wave ECG in patients with lone atrial fibrillation. Europace 2000; 2: 32-41. 10. Holmqvist F, Platonov PG, Havmoller R, Carlson J. Signal-averaged P wave analysis for delineation of interatrial conduction further validation of the method. BMC Cardiovasc Disord 2007; 7: 29. 11. Giacopelli D, Bourke JP, Murray A, Langley P. Spatial pattern of P waves in paroxysmal atrial fibrillation patients in sinus rhythm and controls. Pacing Clin Electrophysiol 2012; 35: 819-26. 12. Colman AM, Giacopelli D, Langley P, Zhang H. Elucidating the body surface P-wave using a detailed computer model. Comput Cardiol 2012; 39: 129-32. 13. Debbas NM, Jackson SH, De Jonghe D, Robert A, Camm AJ. Human atrial repolarization: effects of sinus rate, pacing and drugs on the surface electrocardiogram. J Am Coll Cardiol 1999; 33: 358-65. 14. Hayashi H, Okajima M, Yamada K. Atrial T (Ta) loop in patients with A-V block: a trial to differentiate normal and abnormal groups. Am Heart J 1976; 91: 492-500.